Insider ownership feed
Showing Forms 3/4/5 accepted since 02 Jul 2026. Each row keeps issuer, reporting owner, reported value, role, and SEC evidence together.
Recent insider signals
Use the card actions for issuer context, owner profile, and SEC evidence.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Form 4 insider conviction
Role, issuer, transaction value, repeat activity, and SEC evidence.
Fresh reports
11,484
Forms 3, 4, and 5 filed in the current review window.
Visible buy/sell mix
0/0
Positive/negative net value among the preview cards.
Visible net value
$0
Directional preview only; verify transaction rows and footnotes.
Newest evidence
29 Jul 2026
Use recency to separate fresh activity from stale insider stories.
Signal checks
positive net value and transaction code
multiple insiders or repeated filings
director, officer, or 10% owner context
issuer facts, 13D/G stakes, and 13F holders
SEC-verifiable Form 4 path
Open the filing, then follow the insider, issuer, or related ownership context.
Mohit Kaushal filed Form 4 for Oncology Institute, Inc. (TOI). Role/context: Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
Anne McGeorge filed Form 4 for Oncology Institute, Inc. (TOI). Role/context: Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
Mark L. Pacala filed Form 4 for Oncology Institute, Inc. (TOI). Role/context: Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
Mark Stolper filed Form 4 for Oncology Institute, Inc. (TOI). Role/context: Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
Carl L. Gordon filed Form 4 for Scribe Therapeutics, Inc. (SCTX). Role/context: Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
Kimberly J. Tzoumakas filed Form 4 for Oncology Institute, Inc. (TOI). Role/context: Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
| Security | Issuer | Reporting owner / CIK | Reported value | Report date | Actions |
|---|---|---|---|---|---|
| TOI | Oncology Institute, Inc. | Mohit Kaushal CIK 0001683021 | $0 | 27 Jul 2026 | |
| TOI | Oncology Institute, Inc. | Anne McGeorge CIK 0001779934 | $0 | 27 Jul 2026 | |
| TOI | Oncology Institute, Inc. | Mark L. Pacala CIK 0001321250 | $0 | 27 Jul 2026 | |
| TOI | Oncology Institute, Inc. | Mark Stolper CIK 0001281961 | $0 | 27 Jul 2026 | |
| SCTX | Scribe Therapeutics, Inc. | Carl L. Gordon CIK 0001282930 | $0 | 23 Jul 2026 | |
| TOI | Oncology Institute, Inc. | Kimberly J. Tzoumakas CIK 0001766666 | $0 | 27 Jul 2026 | |
| TOI | Oncology Institute, Inc. | Brad Hively CIK 0001891124 | $0 | 27 Jul 2026 | |
| AAL | American Airlines Group Inc. | Stephen L. Johnson CIK 0001458560 | -$1,345,308 | 27 Jul 2026 | |
| SCTX | Scribe Therapeutics, Inc. | ORBIMED ADVISORS LLC CIK 0001055951 | $0 | 27 Jul 2026 | |
| LMND | Lemonade, Inc. | John Sheldon Peters CIK 0001816299 | $0 | 27 Jul 2026 | |
| TOI | Oncology Institute, Inc. | Karen Marie Johnson CIK 0001892819 | $0 | 27 Jul 2026 | |
| XYZ | Block, Inc. | Anthony Mathew Eisen CIK 0001933928 | -$1,456,800 | 27 Jul 2026 | |
| CIK 0002143673 | Uranium Royalty Corp. | Vina Unka Patel CIK 0002114354 | $0 | 28 Jul 2026 | |
| SON | SONOCO PRODUCTS CO | James A. Harrell III CIK 0001483842 | $0 | 27 Apr 2026 | |
| CIK 0002143673 | Uranium Royalty Corp. | Darcy Dwayne Hirsekorn CIK 0002110605 | $0 | 28 Jul 2026 | |
| MAX | MediaAlpha, Inc. | Eugene Nonko CIK 0001830016 | -$597,007 | 27 Jul 2026 | |
| RS | RELIANCE, INC. | William A. Smith II CIK 0001408793 | -$974,630 | 28 Jul 2026 | |
| CIK 0002143673 | Uranium Royalty Corp. | Kenneth Graham Robertson CIK 0002103199 | $0 | 28 Jul 2026 | |
| GL | GLOBE LIFE INC. | Thomas Peter Kalmbach CIK 0001765569 | -$4,580,564 | 28 Jul 2026 | |
| CIK 0002120416 | Alpha Summit Strategic Alternatives Fund | Starr Frohlich CIK 0002071848 | $0 | 24 Jul 2026 | |
| WEX | WEX Inc. | Ann Elena Drew CIK 0001834871 | -$598,468 | 27 Jul 2026 | |
| WEX | WEX Inc. | Jennifer Kimball CIK 0001903739 | -$208,859 | 27 Jul 2026 | |
| ARX | Accelerant Holdings | Francis James O'Neill CIK 0002008632 | -$3,139,672 | 27 Jul 2026 | |
| MATX | Matson, Inc. | Matthew J. Cox CIK 0001206911 | -$1,998,130 | 29 Jul 2026 | |
| CIK 0002143673 | Uranium Royalty Corp. | Andrew Colin Marshall CIK 0002109732 | $0 | 28 Jul 2026 | |
| TBN | Tamboran Resources Corp | Bryan Sheffield CIK 0001606914 | $0 | 28 May 2026 | |
| WHD | Cactus, Inc. | Cactus WH Enterprises, LLC CIK 0001701768 | $0 | 27 Jul 2026 | |
| WHD | Cactus, Inc. | Scott Bender CIK 0001701688 | -$732,391 | 27 Jul 2026 | |
| NXTC | NextCure, Inc. | ADAR1 Capital Management, LLC CIK 0001940272 | $0 | 27 Jul 2026 | |
| WHD | Cactus, Inc. | Joel Bender CIK 0001701689 | -$732,391 | 27 Jul 2026 | |
| META | Meta Platforms, Inc. | Javier Olivan CIK 0001564475 | -$891,108 | 27 Jul 2026 | |
| CITR | CitroTech Inc. | Stephen Conboy CIK 0001514881 | $0 | 16 Apr 2026 | |
| QUBT | Quantum Computing Inc. | Susan G. Hunt CIK 0002147613 | $0 | 17 Jul 2026 | |
| MUX | McEwen Inc. | Robert Ross McEwen CIK 0001316599 | $0 | 27 Jul 2026 | |
| NXTC | NextCure, Inc. | ADAR1 Capital Management, LLC CIK 0001940272 | $0 | 27 Jul 2026 | |
| GOOGL | Alphabet Inc. | Marsida Saraci CIK 0002138895 | -$149,607 | 29 Jul 2026 | |
| BWB | Bridgewater Bancshares Inc | Jerry J. Baack CIK 0001733126 | -$567,764 | 27 Jul 2026 | |
| NVEC | NVE CORP /NEW/ | Xuan Kelly Wei CIK 0002027035 | $0 | 27 Jul 2026 | |
| FINW | Finwise Bancorp | Robert E. Wahlman CIK 0001488174 | $0 | 28 Jul 2026 | |
| FINW | Finwise Bancorp | James Noone CIK 0001877353 | $0 | 28 Jul 2026 | |
| FINW | Finwise Bancorp | Michael Christopher O'Brien CIK 0001893848 | $0 | 28 Jul 2026 | |
| FINW | Finwise Bancorp | Richard Thiessens CIK 0002010464 | $0 | 28 Jul 2026 | |
| KSS | KOHLS Corp | Niren Chaudhary CIK 0002140320 | $0 | 28 Jul 2026 | |
| FINW | Finwise Bancorp | Kent Landvatter CIK 0001876809 | $0 | 28 Jul 2026 | |
| BFRI | Biofrontera Inc. | Hermann Luebbert CIK 0001886492 | $0 | 28 Jul 2026 | |
| FINW | Finwise Bancorp | Natasha L. Clayton CIK 0002043208 | $0 | 28 Jul 2026 | |
| FINW | Finwise Bancorp | Sarah E. Grotta CIK 0002125710 | $0 | 28 Jul 2026 | |
| FINW | Finwise Bancorp | Juan C. Arias CIK 0002126045 | $0 | 28 Jul 2026 | |
| FINW | Finwise Bancorp | Timothy S. Brosnan CIK 0002125176 | $0 | 28 Jul 2026 | |
| BFRI | Biofrontera Inc. | Eugene Frederick Leffler III CIK 0001952347 | $0 | 28 Jul 2026 |